Nat West Group PLC Amgen Inc Transaction History

Nat West Group PLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	BUY	$255.7 - $288.46 $2.68 Million - $3.02 Million	10,476 Added 123.1%	18,986 $5.47 Million
Q3 2023 Oct 12, 2023	SELL	$218.65 - $271.46 $12,463 - $15,473	-57 Reduced 0.67%	8,510 $2.29 Million
Q2 2023 Jul 25, 2023	SELL	$214.27 - $253.37 $30,212 - $35,725	-141 Reduced 1.62%	8,567 $1.9 Million
Q1 2023 Apr 24, 2023	SELL	$225.79 - $275.2 $1.59 Million - $1.94 Million	-7,043 Reduced 44.71%	8,708 $2.11 Million
Q4 2022 Jan 27, 2023	SELL	$229.03 - $291.01 $46,951 - $59,657	-205 Reduced 1.28%	15,751 $0
Q3 2022 Oct 31, 2022	SELL	$224.46 - $253.15 $568,781 - $641,482	-2,534 Reduced 13.7%	15,956 $3.6 Million
Q2 2022 Jul 20, 2022	BUY	$230.71 - $256.74 $380,210 - $423,107	1,648 Added 9.79%	18,490 $4.5 Million
Q1 2022 May 03, 2022	BUY	$219.27 - $242.57 $818,534 - $905,513	3,733 Added 28.48%	16,842 $4.07 Million
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $492,824 - $563,992	2,478 Added 23.31%	13,109 $2.95 Million
Q3 2021 Oct 26, 2021	BUY	$212.27 - $248.7 $1.04 Million - $1.22 Million	4,896 Added 85.37%	10,631 $2.26 Million
Q2 2021 Jul 21, 2021	BUY	$233.58 - $259.14 $11,445 - $12,697	49 Added 0.86%	5,735 $1.4 Million
Q1 2021 Apr 16, 2021	BUY	$221.91 - $258.6 $18,196 - $21,205	82 Added 1.46%	5,686 $1.42 Million
Q4 2020 Feb 04, 2021	SELL	$216.38 - $257.67 $148,869 - $177,276	-688 Reduced 10.93%	5,604 $1.29 Million
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $1.48 Million - $1.64 Million	6,292 New	6,292 $1.6 Million

3,078

405M

7.56M

7.16M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Nat West Group PLC, based on Form 13F filings with the SEC.

Stay updated on Nat West Group PLC with notifications on news.